BJY Inc.

Based in Chungcheongnam-do, South Korea, founded in 2022, BJY Inc. operates as a company that specializes in research and development of peptides through its eco-friendly based technology called Peptide Multimer Fermentation, which makes the production of peptides much faster and more efficient compared to traditional methods. BJY Inc. specializes in producing high-performance pharmaceutical and cosmetic ingredients via eco-friendly microbial fermentation.

Its product range includes bioactive materials such as PSNAP-8, a hair loss peptide, bio-retinol, Sphingosine 1-Phosphate (S1P), and botulinum toxin derivatives. These products cater to specific skin and hair health concerns, serving a clientele that includes skincare manufacturers, dermatological firms, and cosmetic brands across Asia, Europe, and North America. The company aims to provide sustainable biotechnology solutions by offering ethically sourced and environmentally friendly alternatives to traditional materials. BJY Inc.

's revenue model relies on direct B2B sales to businesses within the pharmaceutical and cosmetic industries. Through partnerships with manufacturers and retailers, BJY provides its proprietary ingredients in bulk orders, under standard purchase agreements. The pricing reflects the high value of its advanced products, including PSNAP-8 and bio-retinol. Collaborations with key industry players ensure a continuous revenue stream while clients gain access to the latest innovations in bioactive technology, addressing the growing demand for sustainable ingredients.

On May 28, 2025, BJY Inc. raised KRW 1 billion in funding from Korea Technology Finance Corporation, which will be allocated to advancing the technology behind its products. The company plans to expand into new markets and geographic regions, although specific markets are not detailed. Upcoming new products are in development, although release dates have not been disclosed.